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ABSTRACT The human rhinovirus 14 (HRV14) protomer, with or without the antiviral compound WIN 52084s, was simulated
using molecular dynamics and rotational symmetry boundary conditions to model the effect of the entire icosahedral capsid.
The protein asymmetrical unit, comprising four capsid proteins (VP1, VP2, VP3, and VP4) and two calcium ions, was solvated
both on the exterior and the interior to fill the inside of the capsid. The stability of the simulations of this large system (800
residues and 6,650 water molecules) is comparable to more conventional globular protein simulations. The influence of the
antiviral compound on compressibility and positional fluctuations is reported. The compressibility, estimated from the density
fluctuations in the region of the binding pocket, was found to be greater with WIN 52084s bound than without the drug,
substantiating previous computations on reduced viral systems. An increase in compressibility correlates with an entropically
more favorable system. In contrast to the increase in density fluctuations and compressibility, the positional fluctuations
decreased dramatically for the external loops of VP1 and the N-terminus of VP3 when WIN 52084s is bound. Most of these
VP1 and VP3 loops are found near the fivefold axis, a region whose mobility was not considered in reduced systems, but can
be observed with this simulation of the full viral protomer. Altered loop flexibility is consistent with changes in proteolytic
sensitivity observed experimentally. Moreover, decreased flexibility in these intraprotomeric loops is noteworthy since the
externalization of VP4, part of VP1, and RNA during the uncoating process is thought to involve areas near the fivefold axis.
Both the decrease in positional fluctuations at the fivefold axis and the increase in compressibility near the WIN pocket are
discussed in relationship to the antiviral activity of stabilizing the virus against uncoating.
INTRODUCTION
Human rhinovirus (HRV), a member of the picornavirus
family, is the cause of approximately 50% of common
colds. The structure of HRV14 (one of more than 100
serotypes of HRV) with and without the antiviral drug, WIN
52084s, has been determined by x-ray crystallography
(Rossmann et al., 1985; Smith et al., 1986). The protein coat
of the capsid has icosahedral symmetry and consists of four
viral proteins: VP1, VP2, VP3, and VP4. These proteins
encapsulate approximately 7200 nucleotides of the viral
positive-stranded RNA. Drugs in the WIN family are effec-
tive inhibitors of viral replication, and one is currently being
investigated as a commercial therapeutic agent (Pevear et
al., 1999). Therefore, determining the mechanism of inhi-
bition of this class of drugs is important and could lead to
further increases in efficacy and to the design of novel
antiviral agents.
WIN drugs are commonly effective inhibitors of multiple
serotypes of HRV and even other picornaviruses, such as
enterovirus and poliovirus (Badger et al., 1988; Chow et al.,
1997; Hendry et al., 1999). A conserved eight-stranded
-sandwich in VP1 makes up part of a canyon, or depres-
sion in the capsid surface, surrounding the fivefold axis of
the capsid. A pocket, which includes part of the interior of
this -sandwich, lies underneath the canyon. The WIN
drugs bind into this pocket, displacing water molecules in
the case of HRV14 and possibly displacing a long chain
molecule, known as pocket factor, that occupies this region
in the crystal structure of some picornaviruses (Mosser and
Rueckert, 1993; Grant et al., 1994). The binding of these
drugs inhibits viral replication (Smith and Baker, 1999) by
either inhibiting the attachment of the intercellular adhesion
molecule-1 (ICAM-1; Pevear et al., 1989) or stabilizing the
capsid and preventing uncoating which is a necessary step
in the viral life cycle (Fox et al., 1986; Rombaut et al., 1991;
Bibler-Muckelbauer et al., 1994). Earlier investigations us-
ing stochastic boundary molecular dynamics of a reduced
viral system found that binding of WIN 52084s to HRV14
increases the compressibility of the capsid (empirically re-
lated to an entropically favored conformational state), and
weakens the long-range correlations in atomic motions
(Phelps and Post, 1995, 1999) as a result of the hydrophobic
nature of WIN 52084s (Phelps et al., 1998). An empirical
correlation between compressibility and the unfolding en-
tropy of globular proteins leads to the suggestion that WIN
52084s stabilizes the protein capsid and prevents uncoating
by increasing the configurational entropy of the capsid. This
basis for antiviral activity predicted from theory is sup-
ported by recent experimental evidence (Tsang et al., 2000).
In the following, we extend earlier molecular dynamics
studies (Phelps et al., 2000) that focused on a localized
region centered on the WIN 52084s binding pocket, by
simulating the time-dependent dynamics of the entire viral
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capsid with and without the drug WIN 52084s, using mo-
lecular dynamics with rotational symmetry boundary con-
ditions (Cagin et al., 1991; Yoneda et al., 1996). Thus, the
effect of an extremely large system (nearly 2  106 protein
and water atoms) with interpenetrating protein chains can be
simulated by taking advantage of the icosahedral symmetry.
Additionally, we investigate the influence of the antiviral
compound on positional fluctuations of the virus and viral
compressibility. WIN 52084s is found to greatly dampen
the fluctuations in loops of the capsid near the fivefold axis.
This observation is intriguing, given the putative role of this
region in uncoating (Fricks and Hogle, 1990; Giranda et al.,
1992; Mosser and Rueckert, 1993; Belnap et al., 2000).
These effects are also discussed in terms of the susceptibil-
ity of the virus to enzymatic cleavage (Lewis et al., 1998).
METHODS
The molecular dynamics calculations for both the free HRV14 and the
HRV14WIN 52084s complex were performed using the CHARMM pro-
gram (Brooks et al., 1983). The icosahedral, rotational boundary method
(Cagin et al., 1991), which effectively reproduces the entire viral capsid,
was implemented with the IMAGES facility within CHARMM. The rota-
tional boundary method utilizes rotational symmetry to form a roughly
spherical object from identical units, in contrast to the space-filling trans-
lational symmetry of periodic boundary methods. Interatomic interactions
were calculated using the minimum image convention, with new coordi-
nate positions for primary and image atoms obtained at each step. An
update of the image list was made at 20-step intervals. At the center of the
icosahedral sphere, primary atoms and image atoms are necessarily sepa-
rated by a distance shorter than the nonbond cutoff distance. As a result, the
interactions between these water molecules are not accurately modeled.
Nevertheless, the effect on the dynamics of the virus from this computa-
tional inaccuracy is assumed to be insignificant, because the inside radius
of the protein shell is 90 Å from the center of the sphere.
Initial velocities were assigned randomly corresponding to 100 K, and
the system was heated to 300 K over a time of 30 ps. The system was
allowed to equilibrate over a 170-ps period. Velocities were scaled during
this period to maintain the temperature near 300 K, with the last scaling at
approximately 80 ps. During the subsequent 800-ps analysis period, the
temperature remained constant on average without velocity scaling. A
force switching function (Steinbach and Brooks, 1994) was used to
smoothly truncate electrostatic and van der Waals nonbonded forces at a
cutoff of 11.0 Å. The covalent bonds to hydrogen atoms were restrained
with the SHAKE algorithm. The equations of motion were integrated using
the Verlet leap-frog algorithm and a time step of 1 fs. A nonbonded list
update was performed every 20 steps. A spherical quadratic potential was
used to restrain exterior water molecules at the outer boundary (Beglov and
Roux, 1994).
The coordinates used for the asymmetrical unit were either HRV14
(protein data bank: 4RHV; Rossmann et al., 1985) or HRV14WIN 52084s
(protein data bank: 2RS1; Smith et al., 1986). The CHARMM version 22
all-hydrogen parameter set was used. Implicit hydrogen parameters for
WIN 52084s (Lybrand and McCammon, 1988) were modified to reflect the
use of explicit hydrogens. Parameters for bond length, bond angle, and
dihedral angle terms, as well as nonbonded interactions, were added or
modified using chemically similar groups from the CHARMM version 22
all-hydrogen parameter set. The partial charges assigned to WIN 52084s
are shown in Table 1.
Electron density at the threefold and fivefold symmetry axes has been
interpreted as calcium ions (Zhao et al., 1997). In order to simulate a
calcium ion located on a symmetry axis under icosahedral boundary
conditions, it was necessary to develop a single-atom model that conforms
to the symmetry requirements. Therefore, the calcium ion was subdivided
according to its location. A sub-calcium ion was placed on the threefold
axis near the carboxylate side chain of Glu 200 of VP3 and on the fivefold
axis near the backbone carbonyl oxygen of Asp 141 of VP1 (Zhao et al.,
1997). These sub-calcium ions, with a charge of 2/5 on the fivefold axis
and  2/3 on the threefold axis, were offset approximately 0.1 Å from the
axis within the asymmetrical unit. An image update was performed to
create the two (for the threefold axis) or four (for the fivefold axis)
sub-calcium ion image neighbors using the icosahedral, rotational symme-
try operations. The primary sub-calcium ion was bonded to all calcium
image neighbors. Each image sub-calcium ion was also bonded to its other
two (for the threefold) or four (for the fivefold) neighbors. Consequently,
these symmetry related sub-calcium ions create an effective pseudo-cal-
cium ion (charge 2) centered directly on the threefold or fivefold axis.
These pseudo-calcium ions are therefore constrained, with no lateral dif-
fusion off the symmetry axis; however, they are free to move along the axis
TABLE 1 Atomic partial charges for WIN 52084s
Name Type Charge Name Type Charge Name Type Charge
C3 CPH2 0.23 H12 HA 0.10 C5* CA 0.12
C4 CPH1 0.16 H21 HAL 0.09 C6* CA 0.12
C5 CPH 0.03 H22 HAL 0.09 H2* HP 0.12
O1 ON6 0.29 H31 HAL 0.09 H3* HP 0.12
N2 NR2 0.41 H32 HAL 0.09 H5* HP 0.12
C31 CT3 0.20 H41 HAL 0.09 H6* HP 0.12
H1 HA 0.10 H42 HAL 0.09 C2 CN6B 0.11
H2 HA 0.10 H51 HAL 0.09 O1 ON6 0.27
H3 HA 0.10 H52 HAL 0.09 N3 NN5 0.40
HC4 HR3 0.10 H61 HAL 0.09 C4 CN6 0.14
C1# CT2 0.09 H62 HAL 0.09 C5 CN6 0.11
C2# CTL2 0.15 H71 HAL 0.09 CM1 CT3 0.23
C3# CTL2 0.18 H72 HAL 0.09 HM1 HA 0.09
C4# CTL2 0.18 O1* OH1 0.40 HM2 HA 0.09
C5# CTL2 0.18 C1* CA 0.11 HM3 HA 0.09
C6# CTL2 0.12 C2* CA 0.12 H1 HN6 0.09
C7# CTL2 0.05 C3* CA 0.12 H2 HN6 0.09
H11 HA 0.10 C4* CA 0.00 H3 HN6 0.09
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and mimic fluctuations in the plane perpendicular to the axis through bond
vibrations between the sub-calcium ions.
In order to solvate the viral capsid, an equilibrated box of TIP3 water
molecules was overlaid on the virus in a series of positions so as to fill the
asymmetrical unit of the capsid. A water molecule within 2.8 Å of any
crystallographic protein atom, calcium ion, WIN 52084s, or other water
molecule was deleted. Water molecules were relaxed by steepest descent
energy minimization while holding the protein, calcium, and WIN 52084s
coordinates fixed. The entire system was then minimized without any
restrictions. A second overlay following the same protocol was done to fill
voids that could result from energy minimization.
RNA, which does not have icosahedral symmetry and is therefore
crystallographically transparent, was not modeled in this simulation.
Instead the viral capsid was filled with water molecules, as illustrated in
Fig. 1.
Fractional density fluctuations around WIN 52084s were calculated
within an 18-Å cube centered at approximately the middle of WIN 52084s.
The fractional density was determined using a constant-volume grid with
0.1 Å spacing by calculating the fraction of grid points that resided within
the van der Waals radius of a protein, WIN 52084s, or water atom.
Fluctuations were determined over a time period of 800 ps with 0.2-ps
increments.
The asymmetrical unit of the simulation has 12,432 protein atoms,
19,953 water atoms, and 2 calcium ions (Fig. 1 c). WIN 52084s is
composed of 54 atoms. Using the symmetry conditions, in effect, the entire
viral capsid consisting of approximately 750,000 protein atoms can be
modeled.
The simulations were performed using a parallel version of CHARMM
27 running on a Beowulf class supercomputer consisting of a cluster of 100
dual Intel Pentium II computers connected with a gigabit network. Using
six processors, 32 ps/day of the HRV14 capsid system were simulated.
Additionally, 5 nodes of a 20-node Intel Pentium III cluster, also with
gigabit network connections, were used and had a performance of 31
ps/day.
RESULTS
The protomeric unit of HRV14 (Fig. 1 B), comprised of four
viral proteins, interacts extensively with neighboring pro-
tomers. The location of the asymmetrical unit is shown in
relation to the entire HRV14 viral capsid in Fig. 1 A. The
solvated asymmetrical unit, with WIN 52084s represented
as space filling atoms, is shown Fig. 1 C with the fivefold
axis running approximately along the right side of the
wedge and the threefold axis along the left side. The cal-
cium ions (magenta spheres) are located near the exterior of
the capsid. Molecular dynamics simulations of solvated
HRV14, with and without WIN 52084s, were calculated for
1 ns and included effects of neighboring protomers by the
use of icosahedral symmetry conditions. In addition to the
icosahedral symmetry conditions, water molecules were
subjected to a quartic boundary force (Beglov and Roux,
1994) at the exterior of the spherical system (160 Å
radius). Both simulation systems were stable based on con-
FIGURE 1 (A) The protomeric
unit of HRV14 (CHARMM energy
minimized x-ray structure) compris-
ing VP1 (blue), VP2 (green), VP3
(red), and VP4 (yellow) in relation to
the whole HRV14 viral capsid. (B) A
larger representation of the proto-
meric unit. (C) The solvated system
(wedge) with water oxygen atoms
represented as cyan spheres and the
calcium ions as purple spheres. The
protomeric unit is related to B by a
90° rotation. These diagrams were
produced with VMD (Humphrey et
al., 1996) and Raster3D (Merritt and
Bacon, 1997).
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servation of energy and maintenance of a constant average
temperature of 300 K. Furthermore, the capsid, with or without
WIN 52084s, remained well solvated for the 1-ns simulation
period; the most radially distant protein atoms remained sol-
vated by three layers of water molecules. Thus, the combina-
tion of a spherical quadratic boundary potential (Beglov and
Roux, 1994) and icosahedral rotational symmetry conditions
(Cagin et al., 1991; Yoneda et al., 1996) maintained the initial
distribution of solvation waters at the exterior boundary.
The root mean square deviations (RMSD) between sim-
ulation coordinate snapshots (taken every 0.2 ps) and the
minimized crystallographic coordinates for the backbone
atoms of HRV14 with and without WIN 52084s are shown
in Fig. 2 A. The RMSD of HRV14WIN 52084s remains
relatively constant over the time of the simulation at ap-
proximately 1.5 Å, a value typical of globular protein sim-
ulations (Post and Dadarlat, 2000). The overall RMSD of
the backbone atoms for HRV14 is slightly larger and aver-
ages approximately 2.0 Å.
The backbone RMSD values shown in Fig. 2, B-E, are for
the separate protein chains of the capsid. Both VP2 and VP3
main chain deviations are fairly constant, whereas VP1 and
VP4 show larger coordinate differences for either the HRV14
or the HRV14WIN 52084 system. An increase in the RMSD
for VP1 in free HRV14 at approximately 510 ps results pri-
marily from motions of the BC, DE, and GH loops of VP1.
The heavy atom RMSD values for the drug, WIN 52084s,
are shown in Fig. 3. The RMSD is4 Å at the beginning of
the simulation, followed by a steady movement closer to the
initial energy-minimized crystallographic position. This
magnitude of coordinate deviation is relatively large. Al-
though it is reasonable that larger coordinate deviations
between simulation and crystallographic structures could
occur for simulations initiated with low resolution or unre-
fined crystallographic coordinates, a previous investigation
did not find such a correspondence (Post and Dadarlat,
2000). Thus, additional simulations were calculated. Similar
RMSD values for WIN 52084s were observed in three
independent trajectories using different initial velocities. In
one of the additional simulations, the RMSD of WIN
52084s after 200 ps was 2.7 Å, yet the RMSD for the backbone
atoms was 1.8 Å, indicating that the overall structure was not
sensitive to the position of the drug. The RMSD values calcu-
lated for WIN 52084s after a best fit superposition to the initial
energy-minimized WIN 52084s coordinates (Fig. 3) are 1 to
1.5 Å, considerably less than the 2 to 4 Å values obtained
without superposition, and indicate that the general shape of
the drug molecule does not vary significantly. Together, these
factors suggest that the observed mobility of the drug in the
pocket is a physical characteristic of the drug molecule rather
than a result of inaccuracy in the initial crystallographic coor-
dinates or assigned velocities. This feature is considered further
in Discussion.
The heavy atom RMSD values for the calcium ions at the
threefold axis, shown in Fig. 4, A and B, are less than those
of the calcium ion at the fivefold axis (Fig. 4, C and D). The
calcium at the fivefold axis moved to a position toward the
exterior of the capsid to become partially solvated and with
less contact with the five symmetry-related carbonyl oxy-
gens of Asn 141 of VP1.
Density fluctuations
The isothermal compressibility was estimated from the sim-
ulations to assess the effect of WIN 52084s and probe the
basis of antiviral activity. Density fluctuations were deter-
FIGURE 2 The RMS coordinate deviation between the simulation struc-
ture and the energy-minimized crystal structure as a function of time for
(A) the protein backbone atoms of HRV14 and HRV14WIN 52084s
(dashed line), (B) the backbone atoms of VP1 and VP2 (dashed line) for
HRV14, (C) the backbone atoms of VP3 and VP4 (dashed) for HRV14,
(D) the backbone atoms of VP1 and VP2 (dashed) for HRV14WIN
52084s, and (E) the backbone atoms of VP3 and VP4 (dashed) for
HRV14WIN 52084s.
FIGURE 3 The RMS coordinate deviation between the energy-mini-
mized crystal structure as a function of time for the heavy atoms of WIN
52084s after orientation with respect to the minimized crystal structure of
the protein (top) or orientation with respect to the WIN 52084s atoms
(bottom).
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mined for an 18-Å cube around the drug, analogous to calcu-
lations from previous stochastic boundary molecular dynamics
simulation (Phelps and Post, 1995). The isothermal compress-
ibility was calculated using the following equation:
T
  	2
V
2kT
where T is the isothermal compressibility,  is the frac-
tional particle density, V is the volume of the cube, and kT
has its usual meaning. T for HRV14 was 14.8  106 bar1
and increases for HRV14WIN52084 to 19.4  106 bar1.
This increase is the same trend found in previously (Table
2) and is consistent with an increase in the entropy in the
presence of WIN 52084s. The more favorable configura-
tional entropy of HRV14WIN52084 would inhibit uncoating.
Positional fluctuations
The RMS fluctuations of the backbone atoms averaged over
the simulation for each protein residue are shown in Fig. 5,
A-F. Estimates from crystallographic temperature factors (B
values) for free HRV14 are also shown and were obtained
using the equation:
R2
1/2 3B/82	1/2.
The qualitative character of the temperature factors is re-
produced well by the simulation for the major proteins VP1,
VP2, and VP3. In particular, the fluctuations of VP1 loops
connecting the strands of the -sandwich (residues 89–99,
136–145, and 154–173) near the fivefold axis of the capsid
correlates with the crystallographic data as shown in Fig. 5
A. A comparison for HRV14WIN52084 is not possible,
because the crystallographic B values are not available.
The fluctuations of the backbone atoms of the capsid with
WIN 52084s bound were compared to the fluctuations of
the capsid without the drug bound. Large changes are seen
in the N-terminal coil region of VP1, the BC loop (residues
89–91), DE loop (residues 136–140), EF loop (residues
156–169), and GH loop (residues 209–210), which have
greatly dampened fluctuations with the drug bound. These
loops are shown from two views in Fig. 6, A and B. The
residues with the color blue represent regions with the
greatest decrease in fluctuations when WIN 52084s is
bound. Additionally, the N-terminus of VP3 had much
smaller fluctuations with WIN 52084s bound.
DISCUSSION
Until the recent advances in computational power, simulat-
ing the protein coat of an entire icosahedral virus would have
been futile. Parallel computing and rotational symmetry meth-
ods have made feasible the simulation of an 800-residue,
fully solvated macromolecular system. The rotational bound-
ary method, which uses icosahedral symmetry to include the
neighboring protomers in the environment of the viral capsid,
is essential, since image protein chains penetrate the asymmet-
rical unit to form substantial inter-protomeric contacts.
Although the viral capsid is a complex system, the sim-
ulations display good stability. Previous simulations of the
virus protomer using either an implicit water model for
solvation or a less extensive wedge of water molecules were
run no longer than 60 ps (Cagin et al., 1991; Yoneda et al.,
1996). For this study of the protomer with WIN 52084s
bound, a system consisting of four protein chains, one multi-
ring drug molecule, calcium ions, and approximately 6600
water molecules had good stability with a backbone RMS
deviation from the minimized structure of only 1.5 Å after 1 ns
of dynamics. Using stochastic boundary molecular dynamics, a
simulation of a 22 Å spherical region of HRV14 centered in
the pocket which contains WIN 52084s had an average RMS
deviation of 1.9 Å after 800 ps. These RMSD values are
similar to globular protein simulations (Post and Dadarlat,
2000) and demonstrate the utility of the rotational symmetry
FIGURE 4 The RMS coordinate deviation between the energy-mini-
mized structure as a function of time for (A) the threefold calcium ion of
HRV14, (B) the threefold calcium ion of HRV14WIN 52084s, (C) the
fivefold calcium ion of HRV14, and (D) the fivefold calcium ion of
HRV14WIN 52084s.
TABLE 2 Calculated isothermal compressibilities
Simulation WIN 52084s T
Icosahedral* boundary no 14.8  106 bar1
Icosahedral* boundary yes 19.4  106 bar1
Stochastic† boundary no 8.9  106 bar1
Stochastic† boundary yes 11.8  106 bar1
*This work.
†Phelps and Post, 1995.
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method and the suitability of the CHARMM force field for
simulating solvated icosahedral viruses.
Effect of WIN 52084s on viral
conformational mobility
The N-terminus of VP3, which appears as an isolated red
coil on the right side of Fig. 1, B and C, is crystallographi-
cally defined in its entirety and forms a -barrel-like struc-
ture with the four other symmetry related N-termini of VP3
around the fivefold axis of the capsid. This structure stabi-
lizes the pentamer by interactions about the fivefold vertex.
The N-terminus of VP3 has much larger fluctuations in the
absence of WIN 52084s than with WIN 52084s bound.
Larger fluctuations in the absence of WIN 52084s are also
seen for the loops at the extremities of the capsid, and near
FIGURE 5 The RMS fluctuations of the backbone atoms calculated from the molecular dynamics trajectory (solid lines), and the scaled temperature or
B factors from crystal structure (dashed line) as a function of residue number for (A) VP1 of HRV14, (B) VP1 of HRV14WIN 52084s, (C) VP2 of HRV14,
(D) VP2 of HRV14WIN 52084s, (E) VP3 of HRV14, and (F) VP3 of HRV14WIN 52084s. The RMS fluctuations were calculated over a time period from
200 to 1000 ps. The decreased fluctuations in VP1 of HRV14WIN 52084s occur in the N-terminal coil region of VP1, the BC loop (residues 89–91), DE
loop (residues 136–140), EF loop (residues 156–169), and GH loop (residues 209–210).
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the fivefold axis (Fig. 6). How WIN 52084s affects so
profoundly the magnitude of the fluctuations of relatively
isolated loop structures distant from the binding pocket is
unclear, but intriguing, given that VP4 and RNA are hy-
pothesized to exit the viral capsid by mechanisms involving
protein contacts at or near the fivefold axes (Mosser and
Rueckert, 1993; Giranda et al., 1992; Belnap et al., 2000).
One model for uncoating suggests externalization of VP4
and RNA at the fivefold axes (Mosser and Rueckert, 1993;
Giranda et al., 1992) which would require a certain confor-
mational flexibility in this region. The large, picosecond-
timescale fluctuations of these intrapentameric loops sug-
gests a substantial conformational flexibility for HRV14
that could facilitate structural transitions required for un-
coating. The diminution in fluctuations, seen here in the
presence of WIN 52084s, could inhibit such externalization
and is consistent with a more rigid structure described by an
earlier computational study (Vaidehi and Goddard, 1997).
Alternatively, low-resolution structural studies of the 135S
particle of poliovirus indicate that the N-terminus of VP1
and VP4 are released by disrupting VP1-VP1 interactions
near the base of the canyon and close to the EF loop by a
pivot-like motion at the fivefold axis (Belnap et al., 2000).
This model would imply flexibility in the BC, DE, EF, and
GH loops, all regions for which the fluctuations are altered
in the presence of WIN 52084s. Thus, the antiviral activity
of inhibiting an uncoating process that involves disruption
of VP1-VP1 interactions can also be understood from the
reduced mobility observed in the simulations.
A greater configurational entropy of poliovirus in the
presence of drug molecules has been measured experimen-
tally (Tsang et al., 2000). Indeed, an increase in entropy was
predicted based on compressibility calculations from simu-
lations of a reduced system (Phelps and Post, 1995). These
previous results are now substantiated with simulations of
an improved model of the full protomer reported here. The
loss of local entropy associated with the reduced fluctua-
tions in the VP1 loops would partially compensate for an
increase in configurational entropy with WIN 52084s bound
(indicated from the increased compressibility measured in
the region of the binding pocket). Such compensation in
entropy has been noted in earlier studies. Structural studies
of adenylate kinase found that the binding of a competitive
inhibitor leads to an increase in protein chain mobility far
from the active site, whereas the region of the protein involved
in binding becomes less mobile (Mu¨ller et al., 1996). Such
compensation effects distant from a binding site have also been
noted in molecular dynamics studies (Post et al., 1986; Harte et
al., 1992). In these earlier reports, specific polar interactions
between an enzyme and a ligand rigidify a previously mobile
active site of the unligated enzyme. As such, the compensatory
changes in mobility are opposite in direction to those of WIN
52084s; association of WIN 52084s, a hydrophobic compound
with nondirectional apolar interactions, leads to higher mobil-
ity in the binding site countered by less mobile loops of VP1
distant from the binding site.
The smaller fluctuations when WIN52084 is bound are
also noteworthy in view of the lack of cleavage by trypsin
of the capsid in limited proteolysis/mass spectrometry stud-
ies (Lewis et al., 1998). These investigators found that
HRV14 is cleaved at a variety of sites during limited pro-
teolysis, but the presence of a WIN compound fully protects
HRV14 against all detectable cleavage. Large amplitude
fluctuations are necessary for proteolysis. Thus, the confor-
FIGURE 6 VP1 of HRV14 capsid with WIN 52084s (magenta) and
calcium ions (purple) with color coded areas showing regions with dimin-
ished fluctuations when WIN 52084s is bound. Green areas represent a
decrease of fluctuations of 0.3 to 0.49 Å and blue areas represent a decrease
of greater than 0.5. VP1 is shown in two orientations: (A) an orientation
similar to Fig. 1 C, and (B) rotated approximately 70° about a vertical axis.
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mational restrictions in the presence of the drug may relate
to the observed protection against proteolytic enzymes. For
example, one cleavage site is reported to be in the BC loop
of VP1, and the binding of the antiviral drug results in a
lowering in the fluctuations at the C-terminal end of the
loop (residues 95–98). These are also residues found to be
important in binding the receptor, ICAM-1, and antibodies
(Smith and Mosser, 1997; Olson et al., 1993).
From these results on limited proteolysis, Lewis and
coworkers (1998) proposed that HRV14 exists in two states,
one represented by the known crystallographic structure and
one with the N-termini of VP1 and VP4 externalized and
accessible to proteolytic cleavage. The transition from one
state to the other is called “breathing” (Li et al., 1994) and
there was postulated to be a small energy barrier to the
transformation. In poliovirus, it appears that breathing oc-
curs at 37°C but not at 25°C, based on the accessibility of
antibodies to residues normally on the interior of the capsid
(Li et al., 1994). The proposal from the simulations of
entropically based stabilization in the presence of the drug
would be consistent with this two-state breathing model,
since the higher configurational entropy of the capsid when
the drug is bound favors the state of the known crystallo-
graphic structure over the state with the interior residues
externalized. Investigating the dynamics by simulations and
computation will help elucidate the physiological motions
of the capsid and the beginnings of the uncoating process.
The position of WIN 52084s was found to deviate more
than the viral protein coordinates from the initial values. It
should be noted in this regard that the ligands in the viral
pocket are found crystallographically to have disordered elec-
tron density and corresponding high B values. Similarly, a
hydrophobic ligand binds in a buried pocket between two
-sheets in fatty-acid binding protein and has high B values
(Eads et al., 1993; Young et al., 1994). The relatively high
mobility of these hydrophobic ligands, as indicated in Table 3
by the ratio of the B value averaged over the atoms of the
ligand to that of the protein atoms, is consistent with the
dynamic behavior of WIN observed in the simulations. The
nondirectional nature of van der Waals forces that associate
WIN 52084s to the pocket region of the drug would be ex-
pected to confer greater flexibility for drug movement than
specific polar or charged interactions. Indeed, it was found that
a suspected hydrogen bond between the nitrogen of the oxazo-
line ring and the amide hydrogen of Asn 219 of VP1 was not
important for drug efficacy (Hadfield et al., 1995).
Calcium ion dynamics
The large fluctuations of the fivefold calcium suggest that
coordination by the symmetry-related backbone carbonyls
of ASN 141 of VP1 is not highly favorable. The ion on the
fivefold axis appears to prefer solvation by water to coor-
dination by the backbone of VP1. On the other hand, the
calcium at the threefold axis has much smaller fluctuations
and appears to be tightly bound to the much more electron-rich
ASP 200 (of VP3) side chain carboxyl groups. It would appear
that the additional flexibility of the side chain would allow
efficient coordination of the calcium ion on the threefold axis,
whereas at the fivefold axis, the coordinated movements of the
backbone would allow less freedom of the carbonyl to opti-
mize ion coordination. Indeed, HRV14 crystals soaked in
EGTA showed no conformational changes despite the loss of
the putative calcium ion on the fivefold axis (Zhao et al.,
1997). Therefore, the calcium ion at the fivefold axis is prob-
ably not a significant stabilizing factor for the protein capsid.
The five symmetry-related backbone carbonyl oxygens could
indeed provide a binding site for a cation (Zhao et al., 1997;
Kalko et al., 1992); however, the cation is not necessary to
maintain this structure at the fivefold axis.
Interestingly, in poliovirus, electron density on the five-
fold axis was attributed to chloride (Hogle et al., 1985).
Additionally, the density of the putative calcium ion in HRV14
and group B coxsackievirus (Zhao et al., 1997; Muckelbauer et
al., 1995) was found to be less at the fivefold than at the
threefold axis. Thus, cation binding at the threefold axis ap-
pears to be more favorable than binding at the fivefold axis and
may not be necessary for interprotomer stability.
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